CAS 413611-93-5

N-2-Biphenylyl-7-nitro-2,1,3-benzoxadiazol-4-aMine

CAS : 413611-93-5

Formule : C₁₈H₁₂N₄O₃

Degré de pureté : 97%

Couleur et forme : Solid

Masse moléculaire : 332.3129

Ref: IN-DA00C0XJ

10074-G5

CAS : 413611-93-5

10074-G5

Degré de pureté : ≥95%

Masse moléculaire : 332.31g/mol

Ref: 54-BUP13086

10074-G5

CAS : 413611-93-5

Formule : C₁₈H₁₂N₄O₃

Masse moléculaire : 332.32

Ref: 4Z-K-031083

10074-G5

CAS : 413611-93-5

10074-G5 is an inhibitor of c-Myc-Max dimerization.

Formule : C₁₈H₁₂N₄O₃

Degré de pureté : 99.51% - 99.94%

Couleur et forme : Solid

Masse moléculaire : 332.31

Ref: TM-T3686

N-2-Biphenylyl-7-nitro-2,1,3-benzoxadiazol-4-aMine

CAS : 413611-93-5

Degré de pureté : 97%

Masse moléculaire : 332.3190002

Ref: 10-F866494

c-Myc Inhibitor II

CAS : 413611-93-5

C-Myc Inhibitor II is a novel inhibitor of c-Myc transcriptional activity. It inhibits the proliferation of hematopoietic cells and has been shown to be effective in animal models of leukemia, lymphoma, and myeloma. C-Myc Inhibitor II also inhibits the growth of human tumor cells in culture. This drug inhibits the expression of genes related to cell cycle regulation, lipid metabolism, and DNA replication. C-Myc Inhibitor II binds to ATP levels, which may account for its ability to inhibit muscle cell proliferation.

Formule : C₁₈H₁₂N₄O₃

Degré de pureté : Min. 95%

Masse moléculaire : 332.31 g/mol

Ref: 3D-NRA61193